Loading…
Lobbying Spend
—
Filings
49
Firms Hired
2
Active Period
2009–2020
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. H.R. 2113, the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act, including medical device product samples reporting. H.R. 2296, the FAIR Drug Pricing Act, including medical device product samples reporting.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2113
More Efficient Tools to Realize Information for Consumers Act
2020 · first_quarter · Firm: BAKER & HOSTETLER LLP
Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. H.R. 2113, the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act, including medical device product samples reporting. H.R. 2296, the FAIR Drug Pricing Act, including medical device product samples reporting.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2296
Further Consolidated Appropriations Act, 2020
2019 · fourth_quarter · Firm: BAKER & HOSTETLER LLP
H.R. 1865, the Further Consolidated Appropriations Act, 2020, specifically Section 501, repeal of the medical device excise tax. S. 692, the Protect Medical Innovation Act. H.R. 2207, the Protect Medical Innovation Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1865
Prescription Drug STAR Act
2019 · fourth_quarter · Firm: BAKER & HOSTETLER LLP
Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. H.R. 2113, the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act, including medical device product samples reporting. H.R. 2296, the FAIR Drug Pricing Act, including medical device product samples reporting.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2113
Protect Medical Innovation Act of 2019
2019 · fourth_quarter · Firm: BAKER & HOSTETLER LLP
H.R. 1865, the Further Consolidated Appropriations Act, 2020, specifically Section 501, repeal of the medical device excise tax. S. 692, the Protect Medical Innovation Act. H.R. 2207, the Protect Medical Innovation Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2207
More Efficient Tools to Realize Information for Consumers Act
2019 · fourth_quarter · Firm: BAKER & HOSTETLER LLP
Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. H.R. 2113, the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act, including medical device product samples reporting. H.R. 2296, the FAIR Drug Pricing Act, including medical device product samples reporting.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2296
Protect Medical Innovation Act of 2019
2019 · fourth_quarter · Firm: BAKER & HOSTETLER LLP
H.R. 1865, the Further Consolidated Appropriations Act, 2020, specifically Section 501, repeal of the medical device excise tax. S. 692, the Protect Medical Innovation Act. H.R. 2207, the Protect Medical Innovation Act.
Client expense: — · Firm income: $60,000
Matched citations: S. 692
Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. H.R. 2113, the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act, including medical device product samples reporting. H.R. 2296, the FAIR Drug Pricing Act, including medical device product samples reporting.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2113
Protect Medical Innovation Act of 2019
2019 · third_quarter · Firm: BAKER & HOSTETLER LLP
S. 692, the Protect Medical Innovation Act. H.R. 2207, the Protect Medical Innovation Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2207
More Efficient Tools to Realize Information for Consumers Act
2019 · third_quarter · Firm: BAKER & HOSTETLER LLP
Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. H.R. 2113, the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act, including medical device product samples reporting. H.R. 2296, the FAIR Drug Pricing Act, including medical device product samples reporting.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2296
Protect Medical Innovation Act of 2019
2019 · third_quarter · Firm: BAKER & HOSTETLER LLP
S. 692, the Protect Medical Innovation Act. H.R. 2207, the Protect Medical Innovation Act.
Client expense: — · Firm income: $60,000
Matched citations: S. 692
Prescription Drug STAR Act
2019 · second_quarter · Firm: BAKER & HOSTETLER LLP
Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid; H.R. 2113, the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act, including medical device product samples reporting; H.R. 2296, the FAIR Drug Pricing Act, including medical device product samples reporting
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2113
Protect Medical Innovation Act of 2019
2019 · second_quarter · Firm: BAKER & HOSTETLER LLP
S. 692, the Protect Medical Innovation Act H.R. 2207, the Protect Medical Innovation Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2207
More Efficient Tools to Realize Information for Consumers Act
2019 · second_quarter · Firm: BAKER & HOSTETLER LLP
Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid; H.R. 2113, the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act, including medical device product samples reporting; H.R. 2296, the FAIR Drug Pricing Act, including medical device product samples reporting
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2296
Protect Medical Innovation Act of 2019
2019 · second_quarter · Firm: BAKER & HOSTETLER LLP
S. 692, the Protect Medical Innovation Act H.R. 2207, the Protect Medical Innovation Act
Client expense: — · Firm income: $60,000
Matched citations: S. 692
Protect Medical Innovation Act of 2019
2019 · first_quarter · Firm: BAKER & HOSTETLER LLP
S. 692, the Protect Medical Innovation Act H.R. 2207, the Protect Medical Innovation Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2207
Protect Medical Innovation Act of 2019
2019 · first_quarter · Firm: BAKER & HOSTETLER LLP
S. 692, the Protect Medical Innovation Act H.R. 2207, the Protect Medical Innovation Act
Client expense: — · Firm income: $60,000
Matched citations: S. 692
Consolidated Appropriations Act, 2018
2018 · first_quarter · Firm: BAKER & HOSTETLER LLP
Policy issues relating to federal healthcare programs. H.R. 1892, the "Bipartisan Budget Act". H.R. 1625, the "Consolidated Appropriations Act".
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1625
Bipartisan Budget Act of 2018
2018 · first_quarter · Firm: BAKER & HOSTETLER LLP
Policy issues relating to federal healthcare programs. H.R. 1892, the "Bipartisan Budget Act". H.R. 1625, the "Consolidated Appropriations Act".
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1892
American Health Care Act of 2017
2017 · fourth_quarter · Firm: BAKER & HOSTETLER LLP
HR 184, Protect Medical Innovation Act HR 1628, the American Health Care Act S 260, Protecting Seniors Access to Medicare Act Policy issues related to Public Law 114-225, the 21st Century Cures Act, specifically implementation of sections relevant to medical technology Public Law 115-52, the FDA Reauthorization Act HR 849, the Protecting Seniors' Access to Medicare Act S 251, the Protecting Medicare from Executive Action Act
Client expense: — · Firm income: $60,000
Matched citations: HR 1628
Protect Medical Innovation Act of 2018
2017 · fourth_quarter · Firm: BAKER & HOSTETLER LLP
HR 184, Protect Medical Innovation Act HR 1628, the American Health Care Act S 260, Protecting Seniors Access to Medicare Act Policy issues related to Public Law 114-225, the 21st Century Cures Act, specifically implementation of sections relevant to medical technology Public Law 115-52, the FDA Reauthorization Act HR 849, the Protecting Seniors' Access to Medicare Act S 251, the Protecting Medicare from Executive Action Act
Client expense: — · Firm income: $60,000
Matched citations: HR 184
Protecting Seniors Access to Medicare Act
2017 · fourth_quarter · Firm: BAKER & HOSTETLER LLP
HR 184, Protect Medical Innovation Act HR 1628, the American Health Care Act S 260, Protecting Seniors Access to Medicare Act Policy issues related to Public Law 114-225, the 21st Century Cures Act, specifically implementation of sections relevant to medical technology Public Law 115-52, the FDA Reauthorization Act HR 849, the Protecting Seniors' Access to Medicare Act S 251, the Protecting Medicare from Executive Action Act
Client expense: — · Firm income: $60,000
Matched citations: HR 849
Protecting Medicare from Executive Action Act of 2017
2017 · fourth_quarter · Firm: BAKER & HOSTETLER LLP
HR 184, Protect Medical Innovation Act HR 1628, the American Health Care Act S 260, Protecting Seniors Access to Medicare Act Policy issues related to Public Law 114-225, the 21st Century Cures Act, specifically implementation of sections relevant to medical technology Public Law 115-52, the FDA Reauthorization Act HR 849, the Protecting Seniors' Access to Medicare Act S 251, the Protecting Medicare from Executive Action Act
Client expense: — · Firm income: $60,000
Matched citations: S 251
Protecting Seniors' Access to Medicare Act of 2017
2017 · fourth_quarter · Firm: BAKER & HOSTETLER LLP
HR 184, Protect Medical Innovation Act HR 1628, the American Health Care Act S 260, Protecting Seniors Access to Medicare Act Policy issues related to Public Law 114-225, the 21st Century Cures Act, specifically implementation of sections relevant to medical technology Public Law 115-52, the FDA Reauthorization Act HR 849, the Protecting Seniors' Access to Medicare Act S 251, the Protecting Medicare from Executive Action Act
Client expense: — · Firm income: $60,000
Matched citations: S 260
American Health Care Act of 2017
2017 · third_quarter · Firm: BAKER & HOSTETLER LLP
HR 184, Protect Medical Innovation Act HR 1628, the American Health Care Act S 260, Protecting Seniors Access to Medicare Act Policy issues related to Public Law 114-225, the 21st Century Cures Act, specifically implementation of sections relevant to medical technology Public Law 115-52, the FDA Reauthorization Act HR 849, the Protecting Seniors' Access to Medicare Act S 251, the Protecting Medicare from Executive Action Act
Client expense: — · Firm income: $60,000
Matched citations: HR 1628
Source: Senate LDA